Semaglutide, a GLP-1R agonist developed by Denmark’s Novo Nordisk as Ozempic, initially for type 2 diabetes, and marketed ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Denmark is investing 80 million euro in a quantum computing project intended to bring a commercial-grade system to the Nordic ...

ISLAMABAD: Pakistan can significantly reduce national health expenditure by controlling obesity by creating awareness and ...

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

A multi-ancestry polygenic risk score could help health care professionals predict a person’s risk for developing obesity ...

Surgeon-performed transoral and transcervical ultrasound detected oropharyngeal tumours with 86% accuracy, outperforming MRI, ...

European pharmaceutical stocks have swooned while the broader market has climbed higher. As a result, stocks in the sector ...

Patients who underwent mitral valve replacement, but not repair, had a higher risk for infective endocarditis than those at a moderate risk for the disease, a Danish study shows.